Crab (Antigen Laboratories, Inc.)
Welcome to the PulseAid listing for the Crab drug offered from Antigen Laboratories, Inc.. This pharmaceutical is classified as a NON-STANDARDIZED ALLERGENIC. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same NON-STANDARDIZED ALLERGENIC drug type category.
| LABELER NAME / MANUFACTURER: | Antigen Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Crab |
| SUBSTANCE NAME: | OPILIO CRAB |
| TYPE: | NON-STANDARDIZED ALLERGENIC |
| PHARMA CLASS: | |
| ROUTE: | INTRADERMAL; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2011-07-22 |
| END MARKETING DATE: | 0000-00-00 |
Crab NON-STANDARDIZED ALLERGENIC Details:
| Item Description | Crab from Antigen Laboratories, Inc. |
| LABELER NAME: | Antigen Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.05(g/mL) |
| START MARKETING DATE: | 2011-07-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49288-0119_28463a0e-70af-4169-b592-df65f4f13a5f |
| PRODUCT NDC: | 49288-0119 |
| APPLICATION NUMBER: | BLA102223 |
Other OPILIO CRAB Pharmaceutical Manufacturers / Labelers:
